Effects of adenotonsillectomy on R-R interval and brain natriuretic peptide levels in children with sleep apnea: A preliminary report

Sleep Medicine

Volumn 12, Issue 7, 2011, Pages 646-651

  Kaditis, Athanasios G ^a   Chaidas, Konstantinos ^a   Alexopoulos, Emmanouel I ^a   Varlami, Vasiliki ^a   Malakasioti, Georgia ^a   Gourgoulianis, Konstantinos ^a  

^a UNIVERSITY OF THESSALY   (Greece)

Author keywords

Brain natriuretic peptide; Cardiac strain; Heart rate variability; Obstructive sleep apnea; Snoring; Sympathetic tone

Indexed keywords

BRAIN NATRIURETIC PEPTIDE;

ADENOTONSILLECTOMY; APNEA HYPOPNEA INDEX; ARTICLE; CHILD; CLINICAL ARTICLE; ELECTROCARDIOGRAM; FEMALE; HUMAN; MALE; OUTCOME ASSESSMENT; POLYSOMNOGRAPHY; PRESCHOOL CHILD; PRIORITY JOURNAL; RR INTERVAL; SCHOOL CHILD; SLEEP APNEA SYNDROME; SLEEP TIME; SYMPATHETIC TONE; TISSUE LEVEL;

ADENOIDECTOMY; CHILD; ELECTROCARDIOGRAPHY; FEMALE; HEART RATE; HUMANS; MALE; NATRIURETIC PEPTIDE, BRAIN; PILOT PROJECTS; POLYSOMNOGRAPHY; SLEEP APNEA, OBSTRUCTIVE; SNORING; SYMPATHETIC NERVOUS SYSTEM; TONSILLECTOMY;

EID: 79960640468     PISSN: 13899457     EISSN: 18785506     Source Type: Journal    
DOI: 10.1016/j.sleep.2011.01.014     Document Type: Article

References (44)

1. Marcus C.L. Pathophysiology of childhood obstructive sleep apnea: current concepts. Respir Physiol 2000, 119:143-154.
2. Marin J.M., Carrizo S.J., Vicente E., Agusti A.G. Long-term cardiovascular outcomes in men with obstructive sleep apnoea-hypopnoea with or without treatment with continuous positive airway pressure: an observational study. Lancet 2005, 365:1046-1053.
3. Guzzetti S., Cogliati C., Turiel M., Crema C., Lombardi F., Malliani A. Sympathetic predominance followed by functional denervation in the progression of chronic heart failure. Eur Heart J 1995, 16:1100-1107.
4. Lavie L., Lavie P. Molecular mechanisms of cardiovascular disease in OSAHS: the oxidative stress link. Eur Respir J 2009, 33:1467-1484.
5. Gozal D., Kheirandish-Gozal L. Cardiovascular morbidity in obstructive sleep apnea: oxidative stress, inflammation, and much more. Am J Respir Crit Care Med 2008, 177:369-375.
6. Somers V.K., Dyken M.E., Clary M.P., Abboud F.M. Sympathetic neural mechanisms in obstructive sleep apnea. J Clin Invest 1995, 96:1897-1904.
7. Garpestad E., Parker J.A., Katayama H., Lilly J., Yasuda T., Ringler J., et al. Decrease in ventricular stroke volume at apnea termination is independent of oxygen desaturation. J Appl Physiol 1994, 77:1602-1608.
8. Sofer S., Weinhouse E., Tal A., Wanderman K.L., Margulis G., Leiberman A., et al. Cor pulmonale due to adenoidal or tonsillar hypertrophy or both in children. Noninvasive diagnosis and follow-up. Chest 1988, 93:119-122.
9. Shiomi T., Guilleminault C., Stoohs R., Schnittger I. Obstructed breathing in children during sleep monitored by echocardiography. Acta Paediatr 1993, 82:863-871.
10. Garpestad E., Katayama H., Parker J.A., Ringler J., Lilly J., Yasuda T., et al. Stroke volume and cardiac output decrease at termination of obstructive apneas. J Appl Physiol 1992, 73:1743-1748.
11. Kaditis A.G., Alexopoulos E.I., Hatzi F., Kostadima E., Kiaffas M., Zakynthinos E., et al. Overnight change in brain natriuretic peptide levels in children with sleep-disordered breathing. Chest 2006, 130:1377-1384.
12. Sans Capdevila O., Crabtree V.M., Kheirandish-Gozal L., Gozal D. Increased morning brain natriuretic peptide levels in children with nocturnal enuresis and sleep-disordered breathing: a community-based study. Pediatrics 2008, 121:e1208-e1214.
13. Stoohs R., Guilleminault C. Cardiovascular changes associated with obstructive sleep apnea syndrome. J Appl Physiol 1992, 72:583-589.
14. O'Driscoll D.M., Foster A.M., Ng M.L., Yang J.S., Bashir F., Nixon G.M., et al. Acute cardiovascular changes with obstructive events in children with sleep disordered breathing. Sleep 2009, 32:1265-1271.
15. Aljadeff G., Gozal D., Schechtman V.L., Burrell B., Harper R.M., Ward S.L. Heart rate variability in children with obstructive sleep apnea. Sleep 1997, 20:151-157.
16. Narkiewicz K., Montano N., Cogliati C., van de Borne P.J., Dyken M.E., Somers V.K. Altered cardiovascular variability in obstructive sleep apnea. Circulation 1998, 98:1071-1077.
17. Liao D., Li X., Rodriguez-Colon S.M., Liu J., Vgontzas A.N., Calhoun S., et al. Sleep-disordered breathing and cardiac autonomic modulation in children. Sleep Med 2010, 11:484-488.
18. Muzumdar H.V., Sin S., Syamaprasad S., Veler H., Kipperman S.M., Arens R. Heart rate variability in children with OSAS before and after tonsilloadenoidectomy. Am J Respir Crit Care Med 2008, [abstract: A705].
19. Constantin E., McGregor C.D., Cote V., Brouillette R.T. Pulse rate and pulse rate variability decrease after adenotonsillectomy for obstructive sleep apnea. Pediatr Pulmonol 2008, 43:498-504.
20. Kuczmarski R.J., Ogden C.L., Guo S.S., Grummer-Strawn L.M., Flegal K.M., Mei Z., et al. 2000 CDC Growth Charts for the United States: methods and development. Vital Health Stat 11 2002, 1-190.
21. Rechtschaffen A., Kales A. A Manual of Standardized Terminology: Techniques and Scoring Systems for Sleep Stages of Human Subjects 1968, UCLA Brain Information Service/Brain Research Institute, Los Angeles.
22. American Sleep Disorders Association EEG arousals: scoring rules and examples: a preliminary report from the Sleep Disorders Atlas Task Force of the American Sleep Disorders Association. Sleep 1992, 15:173-184.
23. American Thoracic Society Standards and indications for cardiopulmonary sleep studies in children. Am J Respir Crit Care Med 1996, 153:866-878.
24. Mourot L., Bouhaddi M., Perrey S., Rouillon J.D., Regnard J. Quantitative Poincare plot analysis of heart rate variability: effect of endurance training. Eur J Appl Physiol 2004, 91:79-87.
25. Nir A., Lindinger A., Rauh M., Bar-Oz B., Laer S., Schwachtgen L., et al. NT-pro-B-type natriuretic peptide in infants and children: reference values based on combined data from four studies. Pediatr Cardiol 2009, 30:3-8.
26. Massin M., von Bernuth G. Normal ranges of heart rate variability during infancy and childhood. Pediatr Cardiol 1997, 18:297-302.
27. Pagani M., Montano N., Porta A., Malliani A., Abboud F.M., Birkett C., et al. Relationship between spectral components of cardiovascular variabilities and direct measures of muscle sympathetic nerve activity in humans. Circulation 1997, 95:1441-1448.
28. Baharav A., Kotagal S., Rubin B.K., Pratt J., Akselrod S. Autonomic cardiovascular control in children with obstructive sleep apnea. Clin Auton Res 1999, 9:345-351.
29. Chaicharn J., Lin Z., Chen M.L., Ward S.L., Keens T., Khoo M.C. Model-based assessment of cardiovascular autonomic control in children with obstructive sleep apnea. Sleep 2009, 32:927-938.
30. Genovesi S., Pieruzzi F., Giussani M., Tono V., Stella A., Porta A., et al. Analysis of heart period and arterial pressure variability in childhood hypertension: key role of baroreflex impairment. Hypertension 2008, 51:1289-1294.
31. Ponikowski P., Anker S.D., Chua T.P., Szelemej R., Piepoli M., Adamopoulos S., et al. Depressed heart rate variability as an independent predictor of death in chronic congestive heart failure secondary to ischemic or idiopathic dilated cardiomyopathy. Am J Cardiol 1997, 79:1645-1650.
32. Singh J.P., Larson M.G., Tsuji H., Evans J.C., O'Donnell C.J., Levy D. Reduced heart rate variability and new-onset hypertension: insights into pathogenesis of hypertension: the Framingham Heart Study. Hypertension 1998, 32:293-297.
33. Kaditis A.G., Alexopoulos E.I., Damani E., Hatzi F., Chaidas K., Kostopoulou T., et al. Urine levels of catecholamines in Greek children with obstructive sleep-disordered breathing. Pediatr Pulmonol 2009, 44:38-45.
34. Brown T.E., Beightol L.A., Koh J., Eckberg D.L. Important influence of respiration on human R-R interval power spectra is largely ignored. J Appl Physiol 1993, 75:2310-2317.
35. Nakagawa O., Ogawa Y., Itoh H., Suga S., Komatsu Y., Kishimoto I., et al. Rapid transcriptional activation and early mRNA turnover of brain natriuretic peptide in cardiocyte hypertrophy. Evidence for brain natriuretic peptide as an " emergency" cardiac hormone against ventricular overload. J Clin Invest 1995, 96:1280-1287.
36. Maeda K., Tsutamoto T., Wada A., Hisanaga T., Kinoshita M. Plasma brain natriuretic peptide as a biochemical marker of high left ventricular end-diastolic pressure in patients with symptomatic left ventricular dysfunction. Am Heart J 1998, 135:825-832.
37. Tal A., Leiberman A., Margulis G., Sofer S. Ventricular dysfunction in children with obstructive sleep apnea: radionuclide assessment. Pediatr Pulmonol 1988, 4:139-143.
38. Kaditis A.G., Alexopoulos E.I., Dalapascha M., Papageorgiou K., Kostadima E., Kaditis D.G., et al. Cardiac systolic function in Greek children with obstructive sleep-disordered breathing. Sleep Med 2010, 11:406-412.
39. Ugur M.B., Dogan S.M., Sogut A., Uzun L., Cinar F., Altin R., et al. Effect of Adenoidectomy and/or Tonsillectomy on Cardiac Functions in Children with Obstructive Sleep Apnea. ORL J Otorhinolaryngol Relat Spec 2008, 70:202-208.
40. Ringler J., Basner R.C., Shannon R., Schwartzstein R., Manning H., Weinberger S.E., et al. Hypoxemia alone does not explain blood pressure elevations after obstructive apneas. J Appl Physiol 1990, 69:2143-2148.
41. Morgan B.J., Denahan T., Ebert T.J. Neurocirculatory consequences of negative intrathoracic pressure vs. Asphyxia during voluntary apnea. J Appl Physiol 1993, 74:2969-2975.
42. Iber C., Ancoli-Israel S., Chesson A., Quan S.F. For the American Academy of Sleep Medicine. The AASM Manual for the Scoring of Sleep and Associated Events: Rules, Terminology and Technical Specifications 2007, American Academy of Sleep Medicine, Westchester, Illinois. 1st ed.
43. Schechter M.S. Technical report: diagnosis and management of childhood obstructive sleep apnea syndrome. Pediatrics 2002, 109:e69.
44. Lipton A.J., Gozal D. Treatment of obstructive sleep apnea in children: do we really know how?. Sleep Med Rev 2003, 7:61-80.